Category Archives: DNA

Assassin #39;s Creed 3 - Trailer
Assassin #39;s Creed III is an upcoming free-roaming action-adventure game for the PS3, PC, Xbox 360, and WiiU that takes place both in a near-future setting and 1775 colonial America. Assassin #39;s Creed III is an upcoming free-roaming action-adventure game for the PS3, PC, Xbox 360, and WiiU that takes place both in a near-future setting and 1775 colonial America. The series places the player in the role of Desmond Miles, descendant of a long line of assassins. His ancestors have been battling the Templars for control of powerful artifacts from an ancient, deceased race. Desmond accesses memories locked inside his DNA through the use of a machine called the Animus in the search for clues and information on the artifacts, as well as gaining the skills of his ancestors as he lives their memories. This is where the majority of the game takes place, through 30 years of the life of Connor Kenway, Desmond #39;s ancestor. The gameplay of the series features fast-paced sword fighting, stealth mechanics, and an intense acrobatic running system based on free running and parkour. Many new weapons are included in ACIII, including a signature tomahawk for Connor. Since the game is set in the wild frontier of colonial America, the developers have included an interesting addition in the form of the signature building climbing and rooftop jumping, by transferring these skills to the forests. Downoload Link : 0.mkFrom:MegaAssassinsFanViews:2 0ratingsTime:03:10More inGaming

Here is the original post:
Assassin's Creed 3 - Trailer - Video

BSB 3411 video presentation (DNA BARCODING IN AUTHENTICATING NATURAL HEALTH PRODUCTS)
From:bsb3133Views:2 0ratingsTime:04:40More inScience Technology

Read more:
BSB 3411 video presentation (DNA BARCODING IN AUTHENTICATING NATURAL HEALTH PRODUCTS) - Video

Privacy vs Personal Genetics
PRIVACY ..Genetics DNA data-baseFrom:TheSONSOFLIBERTYMCViews:0 0ratingsTime:02:13More inNews Politics

Read the original here:
Privacy vs Personal Genetics - Video

Alex O #39;Loughlin_DNA
It #39;s in his DNA - Enough said!! Spreading the Alex love hearts; hearts; hearts; For Thighholster1 - I hope you enjoy 🙂 All vids are in HD 720p. Please be so kind as to leave a thumbs up and comment 🙂 This is a fan video (non-profit), simply adoring Alex. I do not own the rights to either the music (DNA by Little Mix) or the clips (H5.0 by CBS). For entertainment only.From:ilovealexoViews:2 0ratingsTime:02:26More inEntertainment

Read the rest here:
Alex O'Loughlin_DNA - Video

2012-11-07 14:10

Johannesburg - The DNA of a man accused of murdering a Pretoria North woman was found at the crime scene, the North Gauteng High Court in Pretoria heard on Wednesday.

Forensic expert Major Shamil Govan testified that Sipho Masiqa's DNA was found on a cigarette butt at the murder scene.

"The chance of someone else having this DNA is one in 6.8 trillion people," he told the court, adding that the world's population was about seven billion.

"We expect to see this DNA profile again if there were 1 000 earths. The DNA is the same in all areas. It is a match."

Masiqa, 34, Raymond Matshaba, 27 and Bradley Molefe, 34, are accused of murdering Thifhelimbilu Mashau, her 8-month-old baby Avheani, and her 4-year-old daughter Adivhaho in their home in July 2010.

They have pleaded not guilty to the murders, and to charges of robbery with aggravating circumstances, kidnapping, and rape.

No sperm, blood

The State alleges they strangled the two children and robbed their mother of her car and other goods at their Theresa Park home, before taking her to Ga-Rankuwa, where they raped and murdered her.

Govan also testified about condoms found at Mashau's house.

Read more:
DNA links man to Pretoria murder - expert

my dance to DNA xox
its a bad quality but i love to dance and realyy love this song 🙂 xxFrom:lydia bennettViews:0 0ratingsTime:04:06More inPeople Blogs

See the original post:
my dance to DNA xox - Video

ScienceDaily (Nov. 6, 2012) A presentation at the American Society of Human Genetics 2012 meeting updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies into clinical care of newborns, infants and children with anatomical defects whose causes are unknown.

Among the challenges is interpreting how variations in patients' DNA cause or contribute to their medical problems, said Duke University Assistant Professor of Pediatrics Erica E. Davis, Ph.D., who presented the update and is based in the Center for Human Disease Modeling in the university's medical center.

In 2011, the center founded the Duke Task Force for Neonatal Genomics to act as a nucleus for a group of physicians and scientists with the diverse skills sets needed to bridge genetics, genomics, cell biology, ethics and clinical investigation and to offer a "360 degree" view of challenging clinical pediatric cases, Dr. Davis said.

"Strikingly, preliminary analysis of the task force's first year of work has suggested definitive or strong candidate diagnoses in some 90% of the recruited cases," she noted.

During its first year, the task force screened over 150 newborns, infants and children, enrolled 20 patients and developed the capacity to enroll about 100 patients each year.

"Our patients come from the Duke fetal diagnostic center, the Duke intensive care nursery and various pediatric specialty clinics," she said.

In one child with severe epilepsy, the task force used sequencing of the protein-coding regions of the genome (about 2% of the entire human genome) to identify a broken gene that impairs the ability of sodium to move in and out of cells.

"We determined that the child's condition was caused by a new mutation in a gene named SCN2A," Dr. Davis said.

This approach was also used to help diagnose genetic disorders in babies with a variety of conditions including congenital muscle weakness, fluid in the brain and kidney cysts.

"The task force's goal is to create a model of how and when genetic sequencing should be a first-tier diagnostic tool to inform and guide clinical management and treatment of young children with unexplained congenital defects," she said.

View post:
DNA sequencing of infants and children with anatomical defects of unknown causes

Ottawa, ON (PRWEB) November 07, 2012

DNA Genotek, a subsidiary of OraSure Technologies Inc. and a leading provider of products for biological sample collection, today launched GenoFIND Genomic Services, a new offering that delivers nucleic acid extraction and detailed analysis optimized for samples collected with the companys products. The GenoFIND service leverages the companys established expertise with DNA from saliva (Oragene) to deliver superior support, analysis and easy-to-understand reporting of genomic data designed for geneticists and non-geneticists alike.

GenoFIND provides a full range of solutions for industry and academic researchers including: project design consulting (including technology selection), logistics and coordination, automated nucleic acid extraction, whole genome and targeted sequencing, array-based SNP and expression profiling, custom assay development, and full bioinformatic analysis. Available platforms include Illumina, Affymetrix, Life Technologies, Ion Torrent, and others. Services for GenoFIND are performed in a CLIA and CAP certified environment, ensuring quality laboratory procedures.

Our close communications with thousands of customers around the world enables us to recognize a real need for researchers to get much higher levels of support from genomic service providers, said Ian Curry, President, DNA Genotek Inc. To meet this need, we designed GenoFIND to integrate our intimate customer service and expert advice with the higher quality downstream services that our customers need. Our reputation for quality products and service means our customers can now trust us to fulfill an even broader spectrum of their needs, reaching their goals faster and more effectively.

About DNA Genotek

DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), focuses on providing high-quality biological sample collection, stabilization and preparation products. The companys Oragene.Dx product line is the only FDA 510(k) cleared saliva-based collection kit for in vitro diagnostic use. DNA Genotek also offers Research Use Only products to collect and preserve large amounts of DNA or RNA from saliva for use with humans, animals or livestock. The reliability and ease-of-use of the companys products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has a global customer base with thousands of customers in over 100 countries. For more information about DNA Genotek, visit http://www.dnagenotek.com

See the original post here:
DNA Genotek Inc. Launches GenoFIND™ Genomic Services

DNA technology has been used to prove a haul of female mud crabs seized in Sydney were illegally taken from Queensland.

Investigators from Fisheries Queensland are increasingly using DNA technology to prosecute people involved in illegal fishing activities.

In the latest case, tests led to a $35,000 fine for a central Queensland fisherman.

He pleaded guilty in the Gladstone Magistrates Court last month to possessing 232 female mud crabs and attempting to sell them across the border in NSW.

The haul was seized at the Sydney Fish Markets earlier this year after fisheries officers in Queensland were tipped off by an industry contact.

'The suspect later confirmed he had taken the crabs from the Turkey Beach area before freighting them south. This was his third offence of this nature,' Queensland Boating and Fisheries Patrol (QBFP) investigator Deryk Smith said in a statement on Monday.

Crabs from the Queensland coast have a different DNA profile to crabs from other parts of Australia.

Female mud crabs can be lawfully sold in NSW, but they've been protected in Queensland since 1914.

More:
DNA tests help nab illegal Qld crabber

November 6, 2012

Connie K. Ho for redOrbit.com Your Universe Online

Researchers from Arizona State University (ASU) recently revealed novel technology that could help protect against a number of pathogens at lower costs and with improved methods.

A re-engineered bacterium that can quicken the delivery of the DNA vaccines to host cells, the new platform was found to provide complete protection against influenza in mice. The team of investigators believes that the new technique could be manufactured to defend against almost any infection at low cost and will not bring any risk to individuals who are already vaccinated or to other members of the public.

The technology that were describing in this paper can be used to develop a vaccine against any virus, any parasite, any fungus, whereas this was never possible before the development of recombinant attenuated bacterial strains like those produced in our lab, explained Roy Curtiss, director of the Center for Infectious Disease and Vaccinology at ASU, in a prepared statement.

The findings of the study were recently published in the online Early Edition (EE) of the Proceedings of the National Academy of Sciences.

By delivering the DNA vaccine using a recombinant attenuated bacterium, we can get 10,000-100,000 doses per liter of culture, commented the studys lead author Wei Kong, a research assistant professor at ASU, in the statement. This crucial safety feature ensures that Salmonella are unable to persist as living organisms to survive if excreted into the environment.

In completing this project, the scientists faced a number of challenges. For one, they had to make sure that the live pathogenic strains would not lead to illness or migrate into the environment. They also worked to produce orally administrative vaccines that were safe and effective but at reduced costs. The team of investigators ended up pioneering a new technique using Salmonella to deliver a group of disease antigens to the recipient cell. The scientists were able to develop recombinant attenuated Salmonella vaccines (RASVs) that could initiate a significant, system-wide immune response and provide immunity.

The most recent results of the study involve a universal DNA vaccine delivery vehicle that was changed from a delayed-lysis Salmonella strain. With the DNA vaccine, cellular and humoral immune responses would be stimulated against protein antigens and allow the host cells to produce particular gene products. This would allow antigens to be produced and then undergo hosted cell modification.

Here, we were able to deliver a vaccine whose DNA sequence induces the immunized individual to make the protective glycoprotein the way you would during a viral infection, continued Curtiss in the statement.

Read the original here:
DNA Vaccine Technology Paves The Way For Effective, Low Cost Protective Methods